Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ashima S Sahni, Melissa Carlucci, Malik Malik & Bharati Prasad. (2019) Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects. Nature and Science of Sleep 11, pages 241-252.
Read now
Read now
Martin B Scharf. (2006) Sodium oxybate for narcolepsy. Expert Review of Neurotherapeutics 6:8, pages 1139-1146.
Read now
Read now
. (2004) A Reply to “Comment on ‘The Abrupt Cessation of Therapeutically Administered Sodium Oxybate (GHB) May Cause Withdrawal Symptoms’”. Journal of Toxicology: Clinical Toxicology 42:1, pages 125-127.
Read now
Read now
. (2004) Comment on “The Abrupt Cessation of Therapeutically Administered Sodium Oxybate (GHB) May Cause Withdrawal Symptoms”. Journal of Toxicology: Clinical Toxicology 42:1, pages 121-123.
Read now
Read now
Articles from other publishers (40)
Hoda Yahyavi & Alireza Foroumadi. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
869
872
.
Icro Maremmani, Matteo Pacini & Angelo G. I. MaremmaniIcro Maremmani, Matteo Pacini & Angelo G. I. Maremmani. 2023. Dual Disorder Heroin Addicts. Dual Disorder Heroin Addicts
183
195
.
Oki Ishikawa, Stella Hahn & Harly Greenberg. (2022) Pharmacologic Therapy for Narcolepsy. Neurology 18:1, pages 68.
Crossref
Crossref
Janet H. Dailey & Susmita Chowdhuri. 2022. Essentials of Sleep Medicine. Essentials of Sleep Medicine
21
46
.
Anna Heidbreder, Christina Dirks & Markus Ramm. (2020) Therapy for Cataplexy. Current Treatment Options in Neurology 22:4.
Crossref
Crossref
Sally Hu, Mandeep Singh, Jean Wong, Dennis Auckley, Shelley Hershner, Rahul Kakkar, Michael J. ThorpyFrances Chung. (2018) Anesthetic Management of Narcolepsy Patients During Surgery: A Systematic Review. Anesthesia & Analgesia 126:1, pages 233-246.
Crossref
Crossref
Sarah Wurts Black, Akihiro Yamanaka & Thomas S. Kilduff. (2017) Challenges in the development of therapeutics for narcolepsy. Progress in Neurobiology 152, pages 89-113.
Crossref
Crossref
Birgitte R. Kornum, Stine Knudsen, Hanna M. Ollila, Fabio Pizza, Poul J. Jennum, Yves Dauvilliers & Sebastiaan Overeem. (2017) Narcolepsy. Nature Reviews Disease Primers 3:1.
Crossref
Crossref
Seiji Nishino & Nozomu Kotorii. 2016. Narcolepsy. Narcolepsy
285
305
.
Ahmed S. BaHammam, David Nelson Neubauer & Seithikurippu R. Pandi-Perumal. 2015. Drug Treatment of Sleep Disorders. Drug Treatment of Sleep Disorders
231
248
.
Olufemi Adenuga & Hrayr Attarian. (2014) Treatment of Disorders of Hypersomnolence. Current Treatment Options in Neurology 16:9.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2014) Sodium oxybate: a guide to its use in narcolepsy. Drugs & Therapy Perspectives 30:8, pages 282-289.
Crossref
Crossref
Lawrence Scrima. 2014. Primary Care Sleep Medicine. Primary Care Sleep Medicine
269
281
.
Rafael Boscolo-Berto, Guido Viel, Sara Montagnese, Daniella I. Raduazzo, Santo D. Ferrara & Yves Dauvilliers. (2012) Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): A systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews 16:5, pages 431-443.
Crossref
Crossref
Emmanuel J. M. Mignot. (2012) A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes. Neurotherapeutics 9:4, pages 739-752.
Crossref
Crossref
Oliver G Bosch, Boris B Quednow, Erich Seifritz & Thomas C Wetter. (2011) Reconsidering GHB: orphan drug or new model antidepressant?. Journal of Psychopharmacology 26:5, pages 618-628.
Crossref
Crossref
GertJan. Lammers. 2012. Therapy in Sleep Medicine. Therapy in Sleep Medicine
289
296
.
Susmita Chowdhuri. 2012. Essentials of Sleep Medicine. Essentials of Sleep Medicine
17
54
.
Lawrence Scrima. (2010) Dreaming Epiphenomena of Narcolepsy. Sleep Medicine Clinics 5:2, pages 261-275.
Crossref
Crossref
Sanjeev V. KothareJoseph Kaleyias. (2017) Pharmacotherapy of Narcolepsy: Focus on Sodium Oxybate. Clinical Medicine Insights: Therapeutics 2, pages CMT.S1087.
Crossref
Crossref
Seiji Nishino & Nozomu Kotorii. 2010. Narcolepsy. Narcolepsy
251
265
.
Lawrence P. Carter & Roland R. Griffiths. (2009) Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependence 105, pages S14-S25.
Crossref
Crossref
M. Merino-Andréu & A. Martínez-Bermejo. (2009) Narcolepsia con y sin cataplejia: una enfermedad rara, limitante e infradiagnosticada. Anales de Pediatría 71:6, pages 524-534.
Crossref
Crossref
Lawrence P. Carter, Daniel Pardi, Jane Gorsline & Roland R. Griffiths. (2009) Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuse. Drug and Alcohol Dependence 104:1-2, pages 1-10.
Crossref
Crossref
A. K. Goodwin, P. R. Brown, E. E. W. Jansen, C. Jakobs, K. M. Gibson & E. M. Weerts. (2009) Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology 204:3, pages 465-476.
Crossref
Crossref
Ruzica K. Ristanovic, Howard Liang, Carl S. Hornfeldt & Chinglin Lai. (2009) Exacerbation of cataplexy following gradual withdrawal of antidepressants: Manifestation of probable protracted rebound cataplexy. Sleep Medicine 10:4, pages 416-421.
Crossref
Crossref
Joshua T. Kantrowitz, Leslie Citrome & Daniel C. Javitt. (2009) A review of tolerability and abuse liability of γ-hydroxybutyric acid for insomnia in patients with schizophrenia. Clinical Therapeutics 31, pages 1360-1373.
Crossref
Crossref
Qanta A. Ahmed. (2008) Effects of Common Medications Used for Sleep Disorders. Critical Care Clinics 24:3, pages 493-515.
Crossref
Crossref
&NA;. (2007) Sodium oxybate: a guide to its use in narcolepsy. Drugs & Therapy Perspectives 23:8, pages 1.
Crossref
Crossref
Dean M Robinson & Gillian M Keating. (2007) Sodium Oxybate. CNS Drugs 21:4, pages 337-354.
Crossref
Crossref
LAWRENCE S. QUANG. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
803
823
.
Amy K. Goodwin, Roland R. Griffiths, P. Rand Brown, Wolfgang Froestl, Cornelis Jakobs, K. Michael Gibson & Elise M. Weerts. (2006) Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons. Psychopharmacology 189:1, pages 71-82.
Crossref
Crossref
Jonathan RL Schwartz. (2006) Emerging treatment options for excessive sleepiness associated with narcolepsy. Therapy 3:3, pages 375-382.
Crossref
Crossref
Michael D Lemon, Joe D Strain & Debra K Farver. (2016) Formulary Forum: Sodium Oxybate for Cataplexy. Annals of Pharmacotherapy 40:3, pages 433-440.
Crossref
Crossref
Michael J Thorpy. (2006) Cataplexy Associated with Narcolepsy. CNS Drugs 20:1, pages 43-50.
Crossref
Crossref
Elise M. Weerts, Amy K. Goodwin, Roland R. Griffiths, P. Rand Brown, Wolfgang Froestl, Cornelis Jakobs & K. Michael Gibson. (2005) Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons. Psychopharmacology 179:3, pages 678-687.
Crossref
Crossref
William C. Houghton, Thomas E. Scammell & Michael Thorpy. (2004) Pharmacotherapy for cataplexy. Sleep Medicine Reviews 8:5, pages 355-366.
Crossref
Crossref
Asim F Tarabar & Lewis S Nelson. (2004) The ??-Hydroxybutyrate Withdrawal Syndrome. Toxicological Reviews 23:1, pages 45-49.
Crossref
Crossref
David E Fuller, Carl S Hornfeldt, Judy S Kelloway, Pamela J Stahl & Todd F Anderson. (2004) The Xyrem?? Risk Management Program. Drug Safety 27:5, pages 293-306.
Crossref
Crossref
David E. Fuller & Carl S. Hornfeldt. (2012) From Club Drug to Orphan Drug: Sodium Oxybate (Xyrem) for the Treatment of Cataplexy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23:9, pages 1205-1209.
Crossref
Crossref